These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 17652166)
1. Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice. Sha H; Xu J; Tang J; Ding J; Gong J; Ge X; Kong D; Gao X Physiol Genomics; 2007 Oct; 31(2):252-63. PubMed ID: 17652166 [TBL] [Abstract][Full Text] [Related]
2. Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor. Teillon S; Calderon GA; Rios M J Endocrinol; 2010 Apr; 205(1):37-47. PubMed ID: 20097691 [TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes mouse model TallyHo carries an obesity gene on chromosome 6 that exaggerates dietary obesity. Kim JH; Stewart TP; Zhang W; Kim HY; Nishina PM; Naggert JK Physiol Genomics; 2005 Jul; 22(2):171-81. PubMed ID: 15870394 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus. Rao AA; Sridhar GR; Srinivas B; Das UN Med Hypotheses; 2008; 70(2):424-9. PubMed ID: 17553627 [TBL] [Abstract][Full Text] [Related]
5. Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin. Boghossian S; Ueno N; Dube MG; Kalra P; Kalra S Neurobiol Aging; 2007 Oct; 28(10):1594-604. PubMed ID: 17011078 [TBL] [Abstract][Full Text] [Related]
6. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Suwa M; Kishimoto H; Nofuji Y; Nakano H; Sasaki H; Radak Z; Kumagai S Metabolism; 2006 Jul; 55(7):852-7. PubMed ID: 16784955 [TBL] [Abstract][Full Text] [Related]
7. Contrasting obesity phenotypes uncovered by partial leptin receptor gene deletion in transgenic mice. Reichart U; Renner-Müller I; Höflich A; Müller OJ; Franz WM; Wolf E; Müller M; Brem G; Aigner B Biochem Biophys Res Commun; 2000 Mar; 269(2):502-7. PubMed ID: 10708583 [TBL] [Abstract][Full Text] [Related]
8. Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor. Daniel PB; Lux W; Samson AL; Schleuning WD; Niego B; Weiss TW; Tjärnlund-Wolf A; Medcalf RL FEBS J; 2007 May; 274(9):2411-23. PubMed ID: 17419735 [TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Kim JH; Sen S; Avery CS; Simpson E; Chandler P; Nishina PM; Churchill GA; Naggert JK Genomics; 2001 Jun; 74(3):273-86. PubMed ID: 11414755 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870 [TBL] [Abstract][Full Text] [Related]
11. Energy-restricted pair-feeding normalizes low levels of brain-derived neurotrophic factor/tyrosine kinase B mRNA expression in the hippocampus, but not ventromedial hypothalamic nucleus, in diet-induced obese mice. Yu Y; Wang Q; Huang XF Neuroscience; 2009 May; 160(2):295-306. PubMed ID: 19217934 [TBL] [Abstract][Full Text] [Related]
12. Coincidence of loci for glucosuria and obesity in type 2 diabetes-prone KK-Ay mice. Suto J Med Sci Monit; 2008 Feb; 14(2):CR65-74. PubMed ID: 18227763 [TBL] [Abstract][Full Text] [Related]
13. Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage. Tran PV; Akana SF; Malkovska I; Dallman MF; Parada LF; Ingraham HA J Comp Neurol; 2006 Oct; 498(5):637-48. PubMed ID: 16917842 [TBL] [Abstract][Full Text] [Related]
14. Genetic modifiers interact with Cpe(fat) to affect body weight, adiposity, and hyperglycemia. Collin GB; Maddatu TP; Sen S; Naggert JK Physiol Genomics; 2005 Jul; 22(2):182-90. PubMed ID: 15870393 [TBL] [Abstract][Full Text] [Related]
15. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Netea MG; Joosten LA; Lewis E; Jensen DR; Voshol PJ; Kullberg BJ; Tack CJ; van Krieken H; Kim SH; Stalenhoef AF; van de Loo FA; Verschueren I; Pulawa L; Akira S; Eckel RH; Dinarello CA; van den Berg W; van der Meer JW Nat Med; 2006 Jun; 12(6):650-6. PubMed ID: 16732281 [TBL] [Abstract][Full Text] [Related]
16. Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice. Estrada-Smith D; Collins AR; Wang X; Crockett C; Castellani L; Lusis AJ; Davis RC Diabetes; 2006 Aug; 55(8):2265-71. PubMed ID: 16873689 [TBL] [Abstract][Full Text] [Related]
17. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nonogaki K; Strack AM; Dallman MF; Tecott LH Nat Med; 1998 Oct; 4(10):1152-6. PubMed ID: 9771748 [TBL] [Abstract][Full Text] [Related]
18. Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype. Lambin S; van Bree R; Caluwaerts S; Vercruysse L; Vergote I; Verhaeghe J Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E262-71. PubMed ID: 16954332 [TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice. Miyawaki K; Inoue H; Keshavarz P; Mizuta K; Sato A; Sakamoto Y; Moritani M; Kunika K; Tanahashi T; Itakura M Diabetes Res Clin Pract; 2008 Oct; 82(1):33-41. PubMed ID: 18678431 [TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]